CN Stock MarketDetailed Quotes
688767 Hangzhou Biotest Biotech
- 24.78
- +0.30+1.23%
Market Closed Sep 9 15:00 CST
2.64BMarket Cap22.55P/E (TTM)
24.96High24.23Low3.41KlotVolume24.40Open24.48Pre Close8.46MTurnover0.32%Turnover Ratio24.80P/E (Static)106.67MShares35.9252wk High1.12P/B2.64BFloat Cap21.4552wk Low29.38Limit Up106.67MShs Float146.52Historical High19.58Limit Down2.98%Amplitude21.45Historical Low0.80Dividend TTM24.80Avg Price1.54KlotAsk3.23%Div YieldTTM100Lot Size1.71KlotBid
Hangzhou Biotest Biotech Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 25.97%267.16M | 30.81%135.63M | -76.75%442.11M | -82.23%312.24M | -86.08%212.08M | -89.81%103.69M | 4.57%1.9B | 16.86%1.76B | 31.62%1.52B | 106.83%1.02B |
| Operating revenue | 25.97%267.16M | 30.81%135.63M | -76.75%442.11M | -82.23%312.24M | -86.08%212.08M | -89.81%103.69M | 4.57%1.9B | 16.86%1.76B | 31.62%1.52B | 106.83%1.02B |
| Total operating cost | 28.16%181.87M | -1.03%91.14M | -68.55%298.97M | -70.64%216.47M | -78.53%141.91M | -79.31%92.09M | 12.64%950.72M | 11.41%737.33M | 33.67%660.99M | 107.03%445.12M |
| Operating cost | 9.64%137.18M | 26.40%74.82M | -75.18%219.59M | -74.91%181.38M | -79.79%125.12M | -85.16%59.2M | 27.50%884.78M | 28.11%722.79M | 46.92%618.98M | 112.94%399M |
| Operating tax surcharges | 22.62%4.81M | -37.21%1.35M | -72.01%5.46M | -65.59%4.11M | -61.21%3.92M | -64.43%2.15M | 15.71%19.49M | -18.03%11.96M | -17.83%10.1M | 28.10%6.04M |
| Operating expense | 2.45%11.33M | -20.00%4.49M | -2.05%27.88M | -19.73%17.08M | -33.21%11.06M | -21.50%5.61M | 24.24%28.47M | 5.39%21.27M | 13.84%16.56M | 2.54%7.15M |
| Administration expense | 37.35%32.04M | 19.39%13.01M | -10.93%51.33M | -7.00%36.88M | -11.08%23.33M | -12.73%10.89M | 23.36%57.63M | 52.85%39.66M | 79.58%26.23M | 106.38%12.48M |
| Financial expense | 32.44%-33.85M | -493.71%-17.17M | 41.99%-85.76M | 55.99%-66.73M | 37.51%-50.11M | 407.51%4.36M | -8,781.56%-147.85M | -9,700.80%-151.62M | -1,834.26%-80.19M | 137.00%859.19K |
| -Interest expense (Financial expense) | -74.49%22.92K | ---- | -29.75%136.62K | ---- | --89.83K | ---- | -71.32%194.48K | ---- | ---- | ---- |
| -Interest Income (Financial expense) | -11.40%-30.65M | ---- | -98.08%-73.53M | ---- | ---27.51M | ---- | -145.27%-37.12M | ---- | ---- | ---- |
| Research and development | 6.19%30.36M | 48.23%14.65M | -25.63%80.48M | -53.10%43.75M | -58.75%28.59M | -49.56%9.88M | 74.74%108.21M | 142.41%93.28M | 155.72%69.31M | 60.31%19.59M |
| Credit Impairment Loss | 77.37%-500.35K | 138.81%236.68K | -164.96%-3.56M | -169.27%-2.94M | -160.98%-2.21M | -240.19%-609.81K | 261.25%5.48M | 318.60%4.25M | 4,188.18%3.63M | 115.18%434.99K |
| Asset Impairment Loss | 27.49%-5.57M | 38.61%-406K | 25.21%-55.27M | 10.58%-7.8M | 5.36%-7.68M | 27.72%-661.29K | -541.19%-73.91M | -104.60%-8.73M | -152.73%-8.11M | -27.22%-914.96K |
| Other net revenue | ||||||||||
| Fair value change income | ---- | ---- | --0 | -100.98%-64.52K | -101.27%-64.52K | -74.22%1.72M | -92.33%64.52K | --6.6M | --5.09M | --6.68M |
| Invest income | -69.54%1.02M | -174.35%-271.33K | -77.15%3.38M | -60.03%3.74M | -37.62%3.36M | -6.14%364.93K | 6,409.25%14.79M | --9.37M | --5.38M | --388.8K |
| -Including: Investment income associates | ---463.41K | ---286.53K | ---459.5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset deal income | 52.39%-49.76K | ---49.76K | --2.26K | ---103.67K | ---104.52K | --0 | --0 | ---- | ---- | ---- |
| Other revenue | -51.53%887.29K | -64.87%541.94K | 66.59%29.14M | -75.23%2.49M | -77.65%1.83M | -63.00%1.54M | 175.71%17.49M | 829.06%10.06M | 3,523.71%8.19M | 2,154.31%4.17M |
| Operating profit | 24.17%81.08M | 219.09%44.54M | -87.22%116.82M | -91.25%91.09M | -92.56%65.3M | -97.61%13.96M | -5.40%914.34M | 24.47%1.04B | 32.81%877.1M | 113.19%582.91M |
| Add:Non operating Income | -97.69%110.42K | -71.52%2.69K | 5,727.61%608.15K | 1,452.15%12.71M | 491.77%4.77M | 12.24%9.45K | -99.61%10.44K | 520.26%818.8K | 575.83%806.23K | 325.83%8.42K |
| Less:Non operating expense | 5,928.75%4.62K | -99.58%1.25K | -87.52%1.55M | -94.76%340.85K | -100.00%76.56 | -82.94%295.24K | 2,169.19%12.46M | 2,853.53%6.51M | 3,111.54%6.46M | 138,495.84%1.73M |
| Total profit | 15.87%81.18M | 225.77%44.54M | -87.15%115.88M | -90.01%103.46M | -91.96%70.07M | -97.65%13.67M | -6.89%901.9M | 23.80%1.04B | 31.97%871.45M | 112.56%581.19M |
| Less:Income tax cost | 18.07%10.75M | 130.63%5M | -91.76%10.58M | -91.05%13.4M | -92.78%9.1M | -97.52%2.17M | -3.42%128.33M | 28.51%149.77M | 38.31%126.08M | 115.29%87.61M |
| Net profit | 15.54%70.44M | 243.71%39.53M | -86.39%105.3M | -89.83%90.06M | -91.82%60.96M | -97.67%11.5M | -7.44%773.56M | 23.03%885.43M | 30.96%745.37M | 112.08%493.59M |
| Net profit from continuing operation | 15.54%70.44M | 243.71%39.53M | -86.39%105.3M | -89.83%90.06M | -91.82%60.96M | -97.67%11.5M | -7.44%773.56M | 23.03%885.43M | 30.96%745.37M | 112.08%493.59M |
| Less:Minority Profit | -171.77%-1.74M | 75.57%-97.02K | -1,762.54%-1.31M | -329.07%-1.47M | -256.76%-639.88K | -137.52%-397.15K | -103.24%-70.12K | 17.19%640.38K | -5.49%408.19K | 355.55%1.06M |
| Net profit of parent company owners | 17.16%72.18M | 233.05%39.63M | -86.22%106.61M | -89.66%91.53M | -91.73%61.6M | -97.58%11.9M | -7.19%773.63M | 23.04%884.79M | 30.99%744.97M | 111.25%492.53M |
| Earning per share | ||||||||||
| Basic earning per share | 18.97%0.69 | 245.45%0.38 | -86.21%1 | -89.63%0.86 | -91.69%0.58 | -97.62%0.11 | -24.64%7.25 | -7.79%8.29 | -1.83%6.98 | 58.76%4.62 |
| Diluted earning per share | 18.97%0.69 | 245.45%0.38 | -86.21%1 | -89.63%0.86 | -91.69%0.58 | -97.62%0.11 | -24.64%7.25 | -7.79%8.29 | -1.83%6.98 | 58.76%4.62 |
| Other composite income | -18.44%933.32K | -63.81%256.15K | -378.46%-1.57M | -35.59%1.02M | 69.02%1.14M | 5,323.93%707.86K | 92,657.79%563.61K | 2,322.00%1.58M | 667.13%677.05K | 85.47%-13.55K |
| Other composite income of parent company owners | -10.42%922.63K | -60.73%250.18K | -408.46%-1.56M | -35.59%914.87K | 69.02%1.03M | 5,323.93%637.08K | 92,657.62%507.25K | 2,322.00%1.42M | 667.13%609.34K | 85.47%-12.2K |
| Other composite income of minority owners | -90.65%10.7K | -91.57%5.97K | -108.54%-4.81K | -35.59%101.65K | 69.02%114.44K | 5,323.93%70.79K | 92,659.32%56.36K | 2,322.00%157.82K | 667.13%67.7K | 85.47%-1.36K |
| Total composite income | 14.91%71.37M | 225.88%39.79M | -86.60%103.73M | -89.73%91.08M | -91.68%62.11M | -97.53%12.21M | -7.37%774.13M | 23.27%887.01M | 31.06%746.05M | 112.16%493.57M |
| Total composite income of parent company owners | 16.71%73.1M | 218.12%39.88M | -86.43%105.04M | -89.57%92.44M | -91.60%62.63M | -97.45%12.54M | -7.13%774.14M | 23.25%886.21M | 31.08%745.58M | 111.32%492.52M |
| Total composite income of minority owners | -228.92%-1.73M | 72.10%-91.05K | -9,426.87%-1.31M | -271.04%-1.37M | -210.41%-525.45K | -130.87%-326.36K | -100.64%-13.76K | 47.99%798.21K | 7.98%475.9K | 349.61%1.06M |
| Add:Adjusted items effecting total composite income | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg